Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Tensions heighten ahead of first president-opposition chief meeting

    Tensions heighten ahead of first president-opposition chief meeting
  2. 2

    Seoul to provide housing subsidy to married couples with newborns

    Seoul to provide housing subsidy to married couples with newborns
  3. 3

    New celebrity-endorsed therapy for face contouring requires only a pair of rubber bands

    New celebrity-endorsed therapy for face contouring requires only a pair of rubber bands
  4. 4

    Rapper jailed after public street fight with another rapper

    Rapper jailed after public street fight with another rapper
  5. 5

    [KH Explains] No more 'Michael' at Kakao Games

    [KH Explains] No more 'Michael' at Kakao Games
  1. 6

    Woman gets suspended term for injuring boyfriend with knife

    Woman gets suspended term for injuring boyfriend with knife
  2. 7

    Nominee for chief of anti-corruption body pledges 'independence, effectiveness'

    Nominee for chief of anti-corruption body pledges 'independence, effectiveness'
  3. 8

    Med schools expect 1,500+ new admission slots next year

    Med schools expect 1,500+ new admission slots next year
  4. 9

    Samsung chief bolsters ties with Germany’s Zeiss

    Samsung chief bolsters ties with Germany’s Zeiss
  5. 10

    KT launches new mobile plans for foreign residents

    KT launches new mobile plans for foreign residents
피터빈트

SK bioscience to help Thailand set up infrastructure for vaccine manufacturing

By Yonhap

Published : July 5, 2023 - 10:37

    • Link copied

SK bioscience CEO Ahn Jae-yong (2nd from Right) and Thailand's Government Pharmaceutical Organization director Mingkwan Suphanpong (2nd from Left) pose for a photo after signing a memorandum of understanding on vaccine collaboration in Nonthaburi, north of Bangkok, on Tuesday. (Yonhap) SK bioscience CEO Ahn Jae-yong (2nd from Right) and Thailand's Government Pharmaceutical Organization director Mingkwan Suphanpong (2nd from Left) pose for a photo after signing a memorandum of understanding on vaccine collaboration in Nonthaburi, north of Bangkok, on Tuesday. (Yonhap)

SK bioscience Co., a pharmaceutical affiliate of South Korea's SK Group, said Wednesday it has joined hands with Thailand's state-run drugmaker to build vaccine manufacturing and development infrastructure in the Southeast Asian country.

SK bioscience and Thailand's Government Pharmaceutical Organization signed a memorandum of understanding on Tuesday, under which the Korean company will help the country prepare for future pandemics by developing a homegrown vaccine.

As a first step, SK bioscience said it will conclude a separate deal to transfer its technology for SKYCellflu, a cell culture-based influenza vaccine, while GPO will produce the vaccine and use it for the nation's inoculation programs.

Thailand is one of the biggest pharmaceutical markets in Southeast Asia, along with Indonesia and Vietnam, with its revenue expected to grow to 10.4 trillion won ($8 billion) in 2027 from 7.5 trillion won in 2021, according to data from the German market analysis firm Statista.

SK bioscience said the latest MOU with Thailand is part of its "globalization" business strategy, aimed at helping foreign countries with inadequate access to vaccines secure reliable production facilities. (Yonhap)

More from Headlines